Back
T-Cypher Bio

T-Cypher Bio

tcypherbio.com

T-Cypher Bio is an early stage T-cell target and T-cell receptor (TCR) discovery and validation company developing the next generation of TCR-based therapeutics by deploying novel, high-throughput, platforms.

What
Life Sciences
When
Feb 2021
CEO
Thomas Lars Andresen
Status
Private
Investment
Active
OSE Board Director
Claire Brown
PreviousNext